Article Topic
Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report
Online pharmacy-to-pharmacy marketplaces help with inventory management, but they also require vigilance because they carry a higher risk of being exploited by criminals selling black market medicines.
[...]Counterfeit drug crimes typically earn light sentences. How did Safe Chain’s co-owners, the Boyd brothers, end up with 18 and 20 years?
Wire fraud charges drove much higher penalties than the shipping of unsafe medicine into the supply chain, and the Boyds’ sentences were based on the government proving high-dollar, deliberate fraud.
[...]Plea Agreement, USA v Sanjay Kumar
United States District Court Southern District of Texas, Houston Division USA v Sanjay Kumar Plea agreement Filed October 2025 Read the document.
[...]March Drug Importation Madness
For a pretty dead policy idea, bulk drug importation has had a lot of news lately. Get the update!
[...]PSM asks federal agencies to review Hims & Hers’ 2026 Super Bowl ad
On March 10, PSM sent letters to the FDA, FTC, and the Department of Justice asking them to take immediate action to address the ad’s false and misleading promotion of its compounded programs and diagnostic tests.
[...]Cases to watch
PSM watches court cases that have an impact on drug supply chain safety. Click through to these cases to follow along with us.
[...]Case overview: Novartis AG and Genentech v SHARx and Campbell Heights Pharmacy (2026 — ) – ongoing
Novartis and Genentech have filed a Lanham Act complaint against an alternative funding program and a Canadian pharmacy allegedly supplying Canadian Xolair to Michigan patients.
[...]Are dead insects in manufacturing areas enough to disqualify a firm from the FDA’s Green List for makers of GLP-1 API?
Industry experts told us that these two companies are on the FDA’s Green List, despite problematic inspections in late 2024 and early 2025. Learn what the inspectors found.
[...]Prescription Drug Affordability Board Activity, January 2026
Prescription Drug Affordability Board Activity, January 2026 Activities Summary Colorado: At its January meeting, the PDAB discussed ways to improve patient engagement and agreed to accept the dismissal of Amgen v. Mizner. The board’s next meeting will be February 20, 2026. Maryland: Maryland’s next PDAB meeting will be February 23, 2026 at 9:00 AM ET.…
[...]Update on drug importation, February 2026
Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past efforts didn’t pay off financially and raised public health risks. Here’s the state of this issue today.
[...]